Last reviewed · How we verify
NCT06629636
Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.
NA trial testing NMN capsule in Repeated IVF Failure in 60 participants. Currently enrolling.
30 September 2025
Quick facts
| Lead sponsor | Sunkaky Medical Cooperation |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 60 |
| Start date | 20 August 2024 |
| Primary completion | 30 September 2025 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across Japan |
Drugs / interventions tested
- NMN capsule
- Placebo
Conditions studied
- Repeated IVF Failure — all drugs for Repeated IVF Failure →
- Female Infertility — all drugs for Female Infertility →
Sponsor
Sunkaky Medical Cooperation
Who can join
Adults 32 to 42, female only, with Repeated IVF Failure or Female Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to investigate the efficacy of NMN supplementation in enhancing embryo developmental capacity and improving IVF success rates in patients experiencing IVF failures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06629636
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Sunkaky Medical Cooperation trials
Trials by the same sponsor.
- NCT07066267 — Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06629636 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sunkaky Medical Cooperation
- Last refreshed: 8 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06629636.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing